Results 281 to 290 of about 5,260,709 (398)

New approaches in radiotherapy for treatment of advanced ovarian cancer

, 1987
William R. Redwood, Hubert A. Eddy, Omar M. Salazar   +2 more
openalex   +1 more source

p53 gene mutations and protein accumulation in human ovarian cancer. [PDF]

, 1993
Jolanta Kupryjańczyk, Ann D. Thor, Roberta L. Beauchamp, Victoria C. Merritt, S M Edgerton, Douglas A. Bell, David W. Yandell   +6 more
openalex   +1 more source

Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage

Journal of the National Cancer Institute, 2019
L. Peres, K. Cushing-Haugen, M. Köbel, H. Harris, A. Berchuck, M. Rossing, J. Schildkraut, J. Doherty   +7 more
semanticscholar   +1 more source

MAGEA6 Engages a YY1‐Dependent Transcription to Dictate Perineural Invasion in Colorectal Cancer

Advanced Science, EarlyView.
This study investigates the role of MAGEA6 in perineural invasion (PNI) in colorectal cancer (CRC). MAGEA6 promotes CRC invasiveness by inhibiting YY1 ubiquitination, enhancing CXCL1 secretion, and recruiting Schwann cells. These findings highlight the potential of targeting the MAGEA6/YY1/CXCL1 axis for therapeutic strategies against PNI and tumor ...
Hao Wang, Kexin He, Ruixue Huo, Weihan Li, Shan Zhang, Lu‐Ju Jiang, Hao Wu, Minhao Yu, Shu‐Heng Jiang, Junli Xue   +9 more
wiley   +1 more source

Exosomes in Ovarian Cancer: Towards Precision Oncology. [PDF]

Pharmaceuticals (Basel)
Perrone MG, Filieri S, Azzariti A, Armenise D, Baldelli OM, Liturri A, Sardanelli AM, Ferorelli S, Miciaccia M, Scilimati A.   +9 more
europepmc   +1 more source

Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure

, 1994
Benjamin W. Corn, R LANCIANO, Matthew Boente, W. Michael Hunter, John Ladazack, R F Ozols   +5 more
openalex   +1 more source

Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin [PDF]

, 1990
R. Gerritsen van der Hoop, M.E.L. van der Burg, W. W. Bokkel Ten Huinink, Hans C. van Houwelingen, J.P. Neijt   +4 more
openalex   +1 more source

Sortilin‐Mediated Rapid, Precise and Sustained Degradation of Membrane Proteins via mRNA‐Encoded Lysosome‐Targeting Chimera

Advanced Science, EarlyView.
The study identified sortilin as a promising LTR, enabling targeted degradation of oncogenic proteins through an mRNA‐encoded MedTAC strategy. In a mouse model, MedTACPTK7 reduced PTK7 by up to 80%, extended survival, and showed excellent pharmacokinetics without toxicity, providing a scalable platform for targeted therapies.
Xin Chang, Xinyu Qiu, Xiaoning Tong, Shaoju Gan, Weicheng Yi, Sitao Xie, Xiangsheng Liu, Chao Zuo, Weihong Tan   +8 more
wiley   +1 more source

Harnessing Extracellular Vesicles for Targeted Drug Delivery in Ovarian Cancer. [PDF]

Pharmaceutics
Yun JH, Noh YR, Yoo S, Park S, Choi Y, An J, Kim I.   +6 more
europepmc   +1 more source

Mechanisms and modulation of resistance to chemotherapy in ovarian cancer [PDF]

, 1993
Raymond P. Perez, Thomas C. Hamilton, Robert F. Ozols, Robert C. Young   +3 more
openalex   +1 more source